170400 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving growth factors Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
MOLECULAR MARKER FOR DIAGNOSIS, PROGNOSIS EVALUATION, AND TREATMENT OF CARDIAC FIBROSIS
#2METHOD OF PROGNOSIS
#3METHOD FOR IDENTIFYING ANTI-CANCER AGENTS USING AN IN VITRO CELL CULTURE SYSTEM THAT MAINTAINS CANCER CELL STEMNESS
#4DIAGNOSTICS OF PERIODONTITIS
#5DIAGNOSTICS OF GINGIVITIS
#6PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#7SELECTION OF FIBROBLAST DONORS FOR OPTIMIZATION OF ALLOGENEIC FIBROBLAST-MEDIATED REGENERATION
#8Preeclampsia biomarkers and related systems and methods
#9Classification of periodontitis patients
#10METHOD OF ASSESSING WOUND HEALING POTENCY OF A MESENCHYMAL STEM POPULATION AND RELATED METHODS OF SELECTING MESENCHYMAL STEM CELLS AND IDENTIFYING TISSUE AS STARTING MATERIAL FOR PRODUCING A MESENCHYMAL STEM CELL POPULATION
#11Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
#12GINGIVITIS DIAGNOSTIC METHODS, USES AND KITS
#13PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#14Diagnostics of periodontitis based on salivary HGF and MMP-8
#15DIAGNOSTICS OF GINGIVITIS BASED ON SALIVARY IL-1BETA AND HGF
#16Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#17METHODS AND SYSTEMS FOR SCREENING CANDIDATE COMPOUNDS FOR THEIR POTENTIAL TO CAUSE SYSTEMIC OR HEPATIC TOXICITY
#18PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#19METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#20Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
#21PREDICTING TUMOR RESPONSES TO ANTIBODIES AGAINST HEPATOCYTE GROWTH FACTOR (HGF) AND/OR ITS COGNATE RECEPTOR, C-MET
#22Circulating pulmonary hypertension biomarker
#23METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#24Quantifying met protein for cancer treatment
#25METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#26Biomarker panel for assessment of mucosal healing
#27GDF15 AS BIOMARKER FOR DIAGNOSING MITOCHONDRIAL DISEASES
#28HEPATOCYTE GROWTH FACTOR AS MARKER OF PROGNOSIS IN SMALL CELL LUNG CANCER (SCLC)
#29Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#30METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#31Method for rapid detection of hepatocyte growth factor in biological fluids
#32In vitro assay method using immunological technique
#33High affinity binding site of HGFR and methods for identification of antagonists thereof
#34BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOF
#35Monitoring and modulating HGF/HGFR activity
#36METHOD OF IN-VITRO IMMUNOASSAY
#37Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction
#38PYRIDINE OR PYRIMIDINE DERIVATIVE HAVING EXCELLENT CELL GROWTH INHIBITION EFFECT AND EXCELLENT ANTI-TUMOR EFFECT ON CELL STRAIN HAVING AMPLIFICATION OF HGFR GENE
#39METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION
#40DIAGNOSTIC AND PROGNOSTIC ASSAY
#41High affinity binding site of HGFR and methods for identification of antagonists thereof
#42Method for treating cancer or cancer metastasis
#43Method for determining biologically active HGF
#44BIOMARKERS AND METHODS OF TREATMENT
#45Monoclonal Antibodies to Hepatocyte Growth Factor
#46Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#47METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#48COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING PANCREATIC CANCER
#49c-MET kinase binding proteins
#50MONITORING AND MODULATING HGF/HGFR ACTIVITY
#51METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION
#52Synergetic Effects of HGF and Antibacterial Treatment
#53Use of Soluble Fgl2 As An Immunosuppressant
#54METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#55METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION
#56High affinity binding site of HGFR and methods for identification of antagonists thereof
#57DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR DISEASE ASSOCIATED WITH HEPATOCYTE GROWTH FACTOR RECEPTOR
#58Monoclonal Antibodies to Hepatocyte Growth Factor
#59METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION
#60Stationary Phase Antibody Arrays for Trace Protein Analysis
#61Assessment of Biological Activity of Hepatocyte Growth Factor (Hgf)
#62Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
#63Diagnostic Methods Of Multiple Organ Amyloidosis
#64Treating solid tumors with an antibody to hepatocyte growth factor
#65Monoclonal antibodies to hepatocyte growth factor
#66METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#67Methods and Compositions for Inhibiting C-MET Dimerization and Activation
#68Nucleic acid ligands to integrins
#69Monitoring and modulating HGF/HGFR activity
#70c-MET kinase binding proteins
#71Methods and compositions for modulating hepatocyte growth factor activation
#72Methods and compositions for modulating HGF/Met
#73c-Met kinase binding proteins
#74Methods and compositions for inhibiting c-met dimerization and activation
#75Use of soluble fgl2 as an immunosuppressant
#76Drug for regenerating tissue and vessel and method therefor
#77Methods and compositions for modulating HGF/Met
#78Monoclonal antibodies to hepatocyte growth factor